Merian Life Sciences ApS: Financial statements 2023
CVR: 40288589
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Merian Life Sciences ApS (CVR 40288589) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 469,177 and a net result of DKK 330,114 compared with DKK 433,053 the year before. That is a decrease of 21.2% compared with the year before. Equity in the 2023 report amounted to DKK 1,461,334. The solvency ratio was 82.2%.
- Gross Profit
- DKK 469,177
- Profit/Loss
- DKK 330,114
- Equity
- DKK 1,461,334
- Total Assets
- DKK 1,778,830
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 469K | 330K | 1.5M | 0 |
| 2022 | - | 596K | 433K | 1.2M | 0 |
| 2021 | - | 394K | 290K | 930K | 0 |
| 2020 | - | 457K | 334K | 619K | 0 |
| 2019 | - | 345K | 234K | 284K | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Merian Life Sciences ApS has published its annual report for 2022. Gross profit came to DKK 595,585, and the net result was DKK 433,053.
About Merian Life Sciences ApS
Merian Life Sciences ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Menachem and Neil Goldsmith. The company is owned by Birgitte Menachem and Neil Goldsmith. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 280,804 and a net result of DKK -36,911 compared with DKK 835,491 the year before. Equity in the 2025 report amounted to DKK 2,002,914.